心臓読影システムの市場：タイプ、用途、最終用途別-2025-2030年の世界予測

心臓読影システム市場は、2023年に17億1,000万米ドルと評価され、2024年には18億米ドルに達すると予測され、CAGR 5.59%で成長し、2030年には25億米ドルになると予測されています。

心臓読影システムは、血液サンプルから心臓マーカーを迅速かつ正確に読み取ることを目的とした革新的な診断ツールであり、心臓関連疾患の診断とモニタリングに不可欠です。このシステムの必要性は、患者の予後を改善するために効率的で迅速な診断ソリューションが必要とされる、世界の心血管疾患（CVD）の有病率の増加から生じています。その用途は病院、診療所、救急治療室、重症治療室など多岐に渡り、心筋梗塞やその他の心疾患のタイムリーな発見を促進します。最終用途には、ワークフローの効率と診断精度を優先するヘルスケアプロバイダーや検査室が含まれます。

市場成長の主因は、人口の高齢化、CVD罹患率の急増、ポイントオブケア診断の技術進歩です。健康意識の高まりと医療インフラ強化に向けた政府の取り組みが市場拡大をさらに後押しします。アジア太平洋のような新興市場でヘルスケアシステムが診断能力を向上させようとしている地域には、潜在的なビジネスチャンスが眠っています。この機会を生かそうとする企業は、心臓マーカーの感度と特異度を高めるための研究開発に投資し、ヘルスケア・プラットフォーム間でのシームレスなデータ相互運用性を目指して、デジタルヘルス技術との統合を模索すべきです。

しかし課題としては、先進的な心臓マーカーシステムの高額なコストや、臨床検証や承認プロセスを遅らせる規制上のハードルなどがあります。市場のプレーヤーは、一貫した保険償還政策に関する制限に直面しており、特に予算に制約のある環境では、採用率に影響を与える可能性があります。

イノベーションと成長を促進するために、企業は費用対効果が高く、ユーザーフレンドリーな診断ソリューションの開発と、予測的洞察を提供するAI強化アナリティクスのためのパートナーシップの開拓に注力すべきです。さらに、遠隔医療の動向に沿ったポータブルでウェアラブルな診断を模索することで、企業は進化する状況のリーダーとして位置づけられると思われます。心臓読影システム市場は、医療技術の進歩と、導入や規制に関連する課題の両方を反映したダイナミックな市場であり、現代のヘルスケアエコシステムのニーズを満たすための継続的なイノベーションが求められています。

市場力学：急速に進化する心臓読影システム市場の主要市場インサイトを公開

心臓読影システム市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の心血管疾患の有病率の上昇
  • 正確で効率的な心臓診断ソリューションに対する需要の高まり
  • ポイントオブケア検査導入に向けた政府の好意的な取り組み
• 市場抑制要因
  • 高度な心臓リーダーシステムに関連する高コスト
• 市場機会
  • 新興国におけるヘルスケアインフラへの投資の増加
  • 検査能力を向上させるための新しいバイオマーカー開発の進展
• 市場の課題
  • 心臓読影システムにおける運用と技術の複雑さ

ポーターのファイブフォース心臓読影システム市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、心臓読影システム市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心臓読影システム市場における外部からの影響の把握

外部マクロ環境要因は、心臓読影システム市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析心臓読影システム市場における競合情勢の把握

心臓読影システム市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス心臓読影システム市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心臓読影システム市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨心臓読影システム市場における成功への道筋を描く

心臓読影システム市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で心血管疾患の罹患率が上昇
    • 正確で効率的な心臓診断ソリューションに対する需要の増加
    • ポイントオブケア検査のイントロダクション向けた政府の好ましい取り組み
  • 抑制要因
    • 高度な心臓読影システムに伴う高コスト
  • 機会
    • 新興国におけるヘルスケアインフラへの投資増加
    • 検査能力を向上させる新しいバイオマーカーの開発の進歩
  • 課題
    • 心臓読影システムにおける運用上および技術的な複雑さ
• 市場セグメンテーション分析
  • タイプ：大規模病院や診断センター向けのベンチトップ型心臓読影システムの採用が増加
  • アプリケーション：うっ血性心不全の有病率の上昇が採用を促進心臓読影システム
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 心臓読影システムの市場：タイプ別

• ベンチトップ心臓読影システム
• ポータブル心臓読影システム

第7章 心臓読影システムの市場：用途別

• 急性冠症候群（ACS）
• うっ血性心不全（CHF）
• 心筋梗塞（MI）

第8章 心臓読影システムの市場：最終用途別

• クリニック
• 診断検査室
• 病院

第9章 南北アメリカの心臓読影システムの市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の心臓読影システムの市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの心臓読影システムの市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • マインドレイ、新たなアッセイの発売により心臓バイオマーカーポートフォリオを拡大
  • アボット、カーディオバスキュラーシステムズを8億3,760万米ドルで買収へ
  • CiplaがCippointを発売- 非感染性疾患、感染症、その他の健康状態を診断するポイントオブケアデバイス
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agappe Diagnostics Ltd.
• Beckman Coulter, Inc. by Danaher Corporation
• bioMerieux SA
• Boditech Med Inc.
• CardioGenics Inc
• Cipla Limited
• Creative Diagnostics
• F. Hoffmann-La Roche Ltd.
• GE HealthCare Technologies, Inc.
• Hangzhou Laihe Biotech Co., Ltd
• Jarvik Heart, Inc.
• Koninklijke Philips N.V.
• LivaNova PLC
• Medtronic plc
• Mindray Medical International Limited
• Nihon Kohden Corporation
• Polymedco, LLC
• QuidelOrtho Corporation
• SCHILLER AG
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Trinity Biotech PLC
• ZOLL Medical Corporation

LIST OF FIGURES

• FIGURE 1. CARDIAC READER SYSTEM MARKET RESEARCH PROCESS
• FIGURE 2. CARDIAC READER SYSTEM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CARDIAC READER SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CARDIAC READER SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CARDIAC READER SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CARDIAC READER SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CARDIAC READER SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CARDIAC READER SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIAC READER SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIAC READER SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CARDIAC READER SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CARDIAC READER SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIAC READER SYSTEM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CARDIAC READER SYSTEM MARKET DYNAMICS
• TABLE 7. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY BENCHTOP CARDIAC READER SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY PORTABLE CARDIAC READER SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME (ACS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY CONGESTIVE HEART FAILURE (CHF), BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION (MI), BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIAC READER SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CARDIAC READER SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES CARDIAC READER SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC CARDIAC READER SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIAC READER SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM CARDIAC READER SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM CARDIAC READER SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM CARDIAC READER SYSTEM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. CARDIAC READER SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. CARDIAC READER SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

The Cardiac Reader System Market was valued at USD 1.71 billion in 2023, expected to reach USD 1.80 billion in 2024, and is projected to grow at a CAGR of 5.59%, to USD 2.50 billion by 2030.

The Cardiac Reader System is an innovative diagnostic tool designed to offer rapid, accurate readings of cardiac markers from blood samples, essential for diagnosing and monitoring heart-related conditions. The system's necessity stems from the increasing prevalence of cardiovascular diseases (CVDs) globally, which demand efficient and rapid diagnostic solutions to improve patient outcomes. Its application spans across hospitals, clinics, emergency rooms, and critical care units, facilitating the timely detection of myocardial infarction and other cardiac events. The end-use scope includes healthcare providers and laboratories that prioritize workflow efficiency and diagnostic accuracy.

Market growth is primarily driven by the aging population, a spike in CVD incidences, and technological advancements in point-of-care diagnostics. Increasing health awareness and government initiatives to enhance healthcare infrastructure further propel market expansion. Potential opportunities lie in regions like Asia-Pacific, where healthcare systems seek to improve diagnostic capabilities in emerging markets. Companies keen on capitalizing should invest in R&D to enhance the sensitivity and specificity of cardiac markers and to explore integration with digital health technologies, aiming for seamless data interoperability across healthcare platforms.

However, challenges include high costs of advanced Cardiac Reader Systems and regulatory hurdles that slow down clinical validation and approval processes. Market players face limitations regarding consistent insurance reimbursement policies, which can affect adoption rates, especially in budget-constrained settings.

To foster innovation and growth, businesses should focus on developing cost-effective, user-friendly diagnostic solutions and pioneer partnerships for AI-enhanced analytics that provide predictive insights. Additionally, exploring portable, wearable diagnostics that align with telemedicine trends could position companies as leaders in the evolving landscape. The Cardiac Reader System market is dynamic, reflecting both advancements in medical technology and challenges associated with adoption and regulation, demanding continuous innovation to meet the needs of modern healthcare ecosystems.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Reader System Market

The Cardiac Reader System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of cardiovascular diseases across the globe
  • Increasing demand for accurate and efficient cardiac diagnostics solutions
  • Favorable government initiatives for the introduction of point of care testing
• Market Restraints
  • High cost associated with advanced cardiac reader systems
• Market Opportunities
  • Rising investments in healthcare infrastructure in emerging economies
  • Advances in the development of new biomarkers to improve testing capabilities
• Market Challenges
  • Operational and technical complexities in cardiac reader system

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Reader System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Reader System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Reader System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Reader System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Reader System Market

A detailed market share analysis in the Cardiac Reader System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Reader System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Reader System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Reader System Market

A strategic analysis of the Cardiac Reader System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Reader System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agappe Diagnostics Ltd., Beckman Coulter, Inc. by Danaher Corporation, bioMerieux SA, Boditech Med Inc., CardioGenics Inc, Cipla Limited, Creative Diagnostics, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Hangzhou Laihe Biotech Co., Ltd, Jarvik Heart, Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Mindray Medical International Limited, Nihon Kohden Corporation, Polymedco, LLC, QuidelOrtho Corporation, SCHILLER AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Reader System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Benchtop Cardiac Reader System and Portable Cardiac Reader System.
• Based on Application, market is studied across Acute Coronary Syndrome (ACS), Congestive Heart Failure (CHF), and Myocardial Infarction (MI).
• Based on End-use, market is studied across Clinics, Diagnostic Laboratories, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cardiovascular diseases across the globe
    • 5.1.1.2. Increasing demand for accurate and efficient cardiac diagnostics solutions
    • 5.1.1.3. Favorable government initiatives for the introduction of point of care testing
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with advanced cardiac reader systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising investments in healthcare infrastructure in emerging economies
    • 5.1.3.2. Advances in the development of new biomarkers to improve testing capabilities
  • 5.1.4. Challenges
    • 5.1.4.1. Operational and technical complexities in cardiac reader system
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Growing preference of benchtop cardiac reader systems for large hospitals and diagnostic centers
  • 5.2.2. Application: Rising prevalence of congestive heart failure driving the adoption cardiac reader system
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiac Reader System Market, by Type

• 6.1. Introduction
• 6.2. Benchtop Cardiac Reader System
• 6.3. Portable Cardiac Reader System

7. Cardiac Reader System Market, by Application

• 7.1. Introduction
• 7.2. Acute Coronary Syndrome (ACS)
• 7.3. Congestive Heart Failure (CHF)
• 7.4. Myocardial Infarction (MI)

8. Cardiac Reader System Market, by End-use

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Diagnostic Laboratories
• 8.4. Hospitals

9. Americas Cardiac Reader System Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiac Reader System Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiac Reader System Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Mindray Expands Cardiac Biomarker Portfolio with Launch of New Assays
  • 12.3.2. Abbott to acquire Cardiovascular Systems for USD 837.6 million
  • 12.3.3. Cipla launches Cippoint - a point-of-care device for Non-Communicable Diseases, infectious diseases, and other health conditions
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agappe Diagnostics Ltd.
• 3. Beckman Coulter, Inc. by Danaher Corporation
• 4. bioMerieux SA
• 5. Boditech Med Inc.
• 6. CardioGenics Inc
• 7. Cipla Limited
• 8. Creative Diagnostics
• 9. F. Hoffmann-La Roche Ltd.
• 10. GE HealthCare Technologies, Inc.
• 11. Hangzhou Laihe Biotech Co., Ltd
• 12. Jarvik Heart, Inc.
• 13. Koninklijke Philips N.V.
• 14. LivaNova PLC
• 15. Medtronic plc
• 16. Mindray Medical International Limited
• 17. Nihon Kohden Corporation
• 18. Polymedco, LLC
• 19. QuidelOrtho Corporation
• 20. SCHILLER AG
• 21. Siemens Healthineers AG
• 22. Thermo Fisher Scientific Inc.
• 23. Trinity Biotech PLC
• 24. ZOLL Medical Corporation